Society guideline links: Screening for breast cancer

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Evaluation of breast problems" and "Society guideline links: Breast cancer" and "Society guideline links: Hereditary breast and ovarian cancer".)

International

●Multidisciplinary Expert Panel and International Society of Geriatric Oncology (SIOG): Consensus statement for individualizing surveillance mammography for older patients after treatment for early-stage breast cancer (2021)

●World Health Organization (WHO): Position paper on mammography screening (2014)

Canada

●Choosing Wisely Canada: Don't routinely do screening mammography for average risk women aged 40-49. Individual assessment of each woman's preferences and risk should guide the discussion and decision regarding mammography screening in this age group (2020)

●Canadian Task Force on Preventive Health Care (CTFPHC): Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer, update (2018)

●Cancer Care Ontario (CCO): Guideline on magnetic resonance imaging screening of women at high risk for breast cancer (2018)

●CCO: Guideline on breast screening for survivors of breast cancer (2017)

●Canadian Association of Radiologists (CAR): Practice guidelines and technical standards for breast imaging and intervention (2012, modified 2016)

United States

●American College of Radiology (ACR): ACR Appropriateness Criteria on supplemental breast cancer screening based on breast density (2021)

●ACR: ACR Appropriateness Criteria on transgender breast cancer screening (2021)

●American College of Physicians (ACP): A guidance statement on screening for breast cancer in average-risk women (2019)

●American Society of Breast Surgeons (ASBrS): Position statement on screening mammography (2019)

●ACR: ACR Appropriateness Criteria on breast imaging of pregnant and lactating women (2018)

●ACR: Recommendations on breast cancer screening in women at higher-than-average risk (2018)

●ASBrS: Consensus guideline on diagnostic and screening magnetic resonance imaging of the breast (2018)

●American College of Obstetricians and Gynecologists (ACOG): Practice bulletin on breast cancer risk assessment and screening in average-risk women (2017)

●ACR: ACR Appropriateness Criteria on breast cancer screening (2017)

●US Preventive Services Task Force (USPSTF): Final recommendation statement on breast cancer – Screening (2016)

●American Cancer Society (ACS): Guideline on breast cancer screening for women at average risk, update (2015)

●ACOG: Committee opinion for management of women with dense breasts diagnosed by mammography (2015)

●ACR: Breast Imaging Reporting and Data System (BI-RADS) Atlas, 5th edition (2013)

Europe

●European Commission Initiative on Breast Cancer (ECIBC): Manual for breast cancer services – European quality assurance scheme for breast cancer services (2021)

●ECIBC: Breast cancer screening and diagnosis – A synopsis of the European breast guidelines (2020)

●European Commission (EC): European guidelines for breast cancer screening and diagnosis (2017)

India

●Indian Council of Medical Research (ICMR): Consensus document for management of breast cancer (2016)

Australia–New Zealand

●Royal Australian College of General Practitioners (RACGP): Guidelines for preventive activities in general practice – Breast cancer, 9th edition (updated 2018)

Japan

●[In Japanese] Japanese Breast Cancer Society (JBCS): Breast cancer clinical practice guidelines (2022)